The First Affiliated Hospital of Xiamen University
🇨🇳China
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
Recruiting
- Conditions
- TumorCarbonic Anhydrase IX
- First Posted Date
- 2025-05-02
- Last Posted Date
- 2025-05-02
- Target Recruit Count
- 113
- Registration Number
- NCT06956144
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, Xiamen, China
Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC
Phase 2
Not yet recruiting
- Conditions
- Non-Small Cell Lung CancerMyelosuppression
- Interventions
- Drug: Trilaciclib combined with Docetaxel
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-05-08
- Target Recruit Count
- 33
- Registration Number
- NCT06929936
GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL
Phase 1
Recruiting
- Conditions
- Non-hodgkin Lymphoma,B CellRelapsed Non-Hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
- Interventions
- Drug: GB5005 CART
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Target Recruit Count
- 45
- Registration Number
- NCT06875063
- Locations
- 🇨🇳
Bing Xu, Xiamen, Fujian, China
The Relationship Between FAPI Results and Myocardial Fibrosis After Acute Myocardial Infarction
Completed
- Conditions
- Acute Myocardial Infarction (AMI)
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-02-24
- Target Recruit Count
- 30
- Registration Number
- NCT06841549
- Locations
- 🇨🇳
the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
Phase 2
Recruiting
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Drug: veneclax, chidaniline combined with azacitidine (VCA) followed by decitabine + MAG regimen (D-MAG)
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-02-20
- Target Recruit Count
- 66
- Registration Number
- NCT06827899
- Locations
- 🇨🇳
Bing Xu, Xiamen, Fujian, China
Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma
Phase 2
Recruiting
- Conditions
- LymphomaFollicular LymphomaRefractory Lymphoma
- Interventions
- First Posted Date
- 2025-02-13
- Last Posted Date
- 2025-02-13
- Target Recruit Count
- 30
- Registration Number
- NCT06826118
- Locations
- 🇨🇳
Bing Xu, Xiamen, Fujian, China
Two-cycle and Three-cycle Induction Therapy with Modified TPF Regimen Combined and Camrelizumab for LANPC
Phase 2
Recruiting
- Conditions
- Nasopharyngeal NeoplasmsPD-1 InhibitorInduction TherapyComplete ResponseChemotherapy
- Interventions
- Drug: Two-cycle induction chemotherapy + immunotherapyDrug: Three-cycle induction chemotherapy + immunotherapy
- First Posted Date
- 2025-02-06
- Last Posted Date
- 2025-03-04
- Target Recruit Count
- 208
- Registration Number
- NCT06811844
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment
Recruiting
- Conditions
- Postoperative ComplicationsPostoperative PainAcupuncture
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-01-03
- Target Recruit Count
- 110
- Registration Number
- NCT06757023
- Locations
- 🇨🇳
First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
Recruiting
- Conditions
- TumorPD-L1
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2024-12-31
- Target Recruit Count
- 50
- Registration Number
- NCT06754345
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
Phase 1
Recruiting
- Conditions
- Acute Myeloid LeukemiaRelapseRefractory AML
- Interventions
- Drug: CVA
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2025-02-24
- Target Recruit Count
- 30
- Registration Number
- NCT06737523
- Locations
- 🇨🇳
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
© Copyright 2025. All Rights Reserved by MedPath